| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |